JPH1149685A5 - - Google Patents

Info

Publication number
JPH1149685A5
JPH1149685A5 JP1997332549A JP33254997A JPH1149685A5 JP H1149685 A5 JPH1149685 A5 JP H1149685A5 JP 1997332549 A JP1997332549 A JP 1997332549A JP 33254997 A JP33254997 A JP 33254997A JP H1149685 A5 JPH1149685 A5 JP H1149685A5
Authority
JP
Japan
Prior art keywords
geraniaceae
extract
nepalense
zuccarini
thunberg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1997332549A
Other languages
English (en)
Other versions
JPH1149685A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP9332549A priority Critical patent/JPH1149685A/ja
Priority claimed from JP9332549A external-priority patent/JPH1149685A/ja
Publication of JPH1149685A publication Critical patent/JPH1149685A/ja
Publication of JPH1149685A5 publication Critical patent/JPH1149685A5/ja
Pending legal-status Critical Current

Links

Description

すなわち、本発明は、ゲンノショウコ又はその抽出物を有効成分とする抗ヘリコバクター・ピロリ薬及び抗ヘリコバクター・ピロリ用食品を提供するものである。
また、本発明は、ゲンノショウコ又はその抽出物を有効成分とするヘリコバクター・ピロリ菌に起因する胃炎、胃潰瘍又は十二指腸潰瘍予防又は治療薬及び予防又は治療用食品を提供するものである。
【００１１】
【発明の実施の形態】
本発明において用いられる植物はフウロソウ科フウロソウ属（Geranium sp.）ゲンノショウコ（Geranium Thunbergii Siebold et Zuccarini(Geraniaceae)(＝G. nepalense, Sweet, var. Thunberg. Kudo)）である。

Claims (4)

  1. ゲンノショウコ（Geranium Thunbergii Siebold et Zuccarini(Geraniaceae)(＝G. nepalense, Sweet, var. Thunberg. Kudo)）又はその抽出物を有効成分とする抗ヘリコバクター・ピロリ薬。
  2. ゲンノショウコ（ Geranium Thunbergii Siebold et Zuccarini(Geraniaceae)( ＝ G. nepalense, Sweet, var. Thunberg. Kudo) ）又はその抽出物を有効成分とするヘリコバクター・ピロリ菌に起因する胃炎、胃潰瘍又は十二指腸潰瘍予防又は治療薬。
  3. ゲンノショウコ（Geranium Thunbergii Siebold et Zuccarini(Geraniaceae)(＝G. nepalense, Sweet, var. Thunberg. Kudo)）又はその抽出物を有効成分とする抗ヘリコバクター・ピロリ用食品。
  4. ゲンノショウコ（ Geranium Thunbergii Siebold et Zuccarini(Geraniaceae)( ＝ G. nepalense, Sweet, var. Thunberg. Kudo) ）又はその抽出物を有効成分とするヘリコバクター・ピロリ菌に起因する胃炎、胃潰瘍又は十二指腸潰瘍予防又は治療用食品。
JP9332549A 1997-06-03 1997-12-03 胃炎、胃潰瘍又は十二指腸潰瘍予防・治療剤 Pending JPH1149685A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9332549A JPH1149685A (ja) 1997-06-03 1997-12-03 胃炎、胃潰瘍又は十二指腸潰瘍予防・治療剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP16052197 1997-06-03
JP9-160521 1997-06-03
JP9332549A JPH1149685A (ja) 1997-06-03 1997-12-03 胃炎、胃潰瘍又は十二指腸潰瘍予防・治療剤

Publications (2)

Publication Number Publication Date
JPH1149685A JPH1149685A (ja) 1999-02-23
JPH1149685A5 true JPH1149685A5 (ja) 2005-07-07

Family

ID=26487005

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9332549A Pending JPH1149685A (ja) 1997-06-03 1997-12-03 胃炎、胃潰瘍又は十二指腸潰瘍予防・治療剤

Country Status (1)

Country Link
JP (1) JPH1149685A (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002029979A (ja) * 2000-07-12 2002-01-29 Kanebo Ltd ヒスタミンｈ２受容体拮抗剤及び皮膚外用剤
KR100440918B1 (ko) * 2001-10-12 2004-07-21 롯데제과주식회사 츄잉껌과 그의 조성물

Similar Documents

Publication Publication Date Title
AU6517496A (en) Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
MY116896A (en) Taste of active pharmaceutical ingredients.
CA2251886A1 (en) An oral pharmaceutical formulation containing ibandronate
AU2190697A (en) Buccal polar spray or capsule
HU0002316D0 (en) Flash-melt oral dosage formulation
EP0151344A3 (en) A chewing gum composition, a process for preparing a chewing gum tablet therefrom, and a chewing gum tablet
PL318954A1 (en) Encapsulated composition of venafaxine hydrochloride of prolonged release
EP0348808A3 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung
EP1262192A3 (en) Compositions and methods for human gastrointestinal health
CA2154424A1 (en) 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect
EP1779730A3 (en) Synergistic and residual pesticidal compositions containing plant essential oils
IL114641A0 (en) Pharmaceutical compositions containing fluoxetine
CA2108455A1 (en) Pharmaceutical compositions against gastric disorders
PL319585A1 (en) Vitamins and calcium, containing therapeutic composition in the unit galenic form of tablets, method of obtaining same and application thereof
WO2002023995A8 (en) Method of blocking free radical processes which result in media ted pathology without deleterious pro-oxidant side reactions
CA2271162A1 (en) Stearidonic acid compositions and uses thereof
CA2266486A1 (en) Rotavirus vaccine formulations
BG104758A (en) Pharmaceutical combinations containing tramadol
WO2001028526A3 (en) Gastroresistant tablets for alimentary, dietetic and therapeutic use
WO1998032428A3 (en) Compositions comprising choline and use of choline to treat endotoxic shock
JPH1149685A5 (ja)
DE60013526D1 (de) Zusammensetzung enthaltend Verbindungen mit adrenergischer Aktivität und pflanzliche Extrakten von Crataegus und Gingko zur Behandlung von Übergewicht und Fettleibigkeit
WO1999059523A3 (en) Topical pharmaceutical compositions useful for the treatment of cutaneous or circulatory pathologies on inflammatory, immune, proliferative or degenerative basis
CA2089748A1 (en) Pharmaceutical compositions containing 5-difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders
AU5816298A (en) Taste masking for unpalatable formulations